![Brian Stal](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Brian Stal
Direttore/Membro del Consiglio presso
Imidomics, Inc.
Profilo
Brian Stal is currently Director at Imidomics, Inc. and Director of GSD at DNS Capital LLC since 2019.
Formerly, Mr. Stal was Principal at The Pritzker Organization LLC from 2013 to 2022 and Board Member at Greycastle Holdings Ltd. from 2014 to 2018.
Education includes an undergraduate degree from the University of Wisconsin in 2003 and an MBA from The University of Chicago Booth School of Business in 2008.
Posizioni attive di Brian Stal
| Società | Posizione | Inizio |
|---|---|---|
DNS Capital LLC
 DNS Capital LLC Investment ManagersFinance DNS Capital invests in middle market companies located in the United States with an EBITDA of USD 10 - 50 million. The firm focuses on a board range of sectors and industries. It provides financing for early and later stage capital requirements with an investment size ranging from USD 25 - 100 million and acquire minority stakes. | Investitore di Private Equity | 01/06/2019 |
Imidomics, Inc.
 Imidomics, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in discovery and development of medicines for immune-mediated inflammatory diseases | Direttore/Membro del Consiglio | - |
Precedenti posizioni note di Brian Stal
| Società | Posizione | Fine |
|---|---|---|
The Pritzker Organization LLC
 The Pritzker Organization LLC Investment ManagersFinance The Pritzker Organization invests in companies located in the United States with an enterprise value of USD 100 - 1000 billion and an EBITDA of USD 10 - 150 million. The firm targets companies operating across a broad range of sectors and industries. It provides financing for growth stage capital requirements with an investment size of USD 75 -300 million for majority deals & USD 15 - 100 million for minority and structured deals. The firm also acquires majority and minority interest. | Investitore di Private Equity | 31/12/2022 |
Greycastle Holdings Ltd.
 Greycastle Holdings Ltd. Financial ConglomeratesFinance Operates as an investment holding company | Direttore/Membro del Consiglio | 30/04/2018 |
Formazione di Brian Stal
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
95
Relazioni di 1° grado
6
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 6 |
|---|---|
University of Wisconsin
 University of Wisconsin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Pritzker Organization LLC
The Pritzker Organization LLC Investment ManagersFinance The Pritzker Organization invests in companies located in the United States with an enterprise value of USD 100 - 1000 billion and an EBITDA of USD 10 - 150 million. The firm targets companies operating across a broad range of sectors and industries. It provides financing for growth stage capital requirements with an investment size of USD 75 -300 million for majority deals & USD 15 - 100 million for minority and structured deals. The firm also acquires majority and minority interest. | Finance |
The University of Chicago Booth School of Business
 The University of Chicago Booth School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Greycastle Holdings Ltd.
Greycastle Holdings Ltd. Financial ConglomeratesFinance Operates as an investment holding company | Finance |
DNS Capital LLC
DNS Capital LLC Investment ManagersFinance DNS Capital invests in middle market companies located in the United States with an EBITDA of USD 10 - 50 million. The firm focuses on a board range of sectors and industries. It provides financing for early and later stage capital requirements with an investment size ranging from USD 25 - 100 million and acquire minority stakes. | Finance |
Imidomics, Inc.
Imidomics, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in discovery and development of medicines for immune-mediated inflammatory diseases | Commercial Services |
